PerkinElmer Inc
LSE:0KHE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
100.004
127.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
PerkinElmer Inc
Income from Continuing Operations
PerkinElmer Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PerkinElmer Inc
LSE:0KHE
|
Income from Continuing Operations
$258.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$3.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
3%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Income from Continuing Operations
$795.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
19%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
16%
|
|
PerkinElmer Inc
Glance View
PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.
See Also
What is PerkinElmer Inc's Income from Continuing Operations?
Income from Continuing Operations
258.3m
USD
Based on the financial report for Sep 29, 2024, PerkinElmer Inc's Income from Continuing Operations amounts to 258.3m USD.
What is PerkinElmer Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%
Over the last year, the Income from Continuing Operations growth was 21%. The average annual Income from Continuing Operations growth rates for PerkinElmer Inc have been -39% over the past three years , 2% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
